Monday, August 6, 2007

Embedded: A Benign Way to Nanowire Living Cells

One day it may be possible for physicians to use electrical stimulation to guide the development of embryonic stem cells into neurons, heart cells, lung cells, breast cells, muscles, and other specific cell types. Researchers with Berkeley Lab and UC Berkeley, in collaboration with researchers at the Gladstone Institute of Cardiovascular Disease (GICD) in San Francisco, have taken a critical first step toward that goal.



Science image Spacer image


A scanning electron microscope reveals individual mouse embryonic stem cells penetrated by silicon nanowires.


The researchers have developed a technique by which silicon nanowires can be embedded in a living cell, with no apparent harm to the cell. The technique can be used to connect individual cells to one another and to wire the cells to external sensors and other electronic devices. It may also have the potential to deliver genetic material to specific organelles within a cell.

"This is the first example of nanowires interfacing with biological cells without the use of external force," says chemist Peidong Yang, who led the research. "The cells were cultured on a silicon substrate that was topped with a vertically aligned silicon nanowire array. The embedding of the silicon nanowire array into individual cells naturally occurred during cell incubation."

Yang is a leading nanoscience authority who holds joint appointments with Berkeley Lab's Materials Sciences Division and Molecular Foundry, and with the UC Berkeley Chemistry Department. He worked with Woong Kim and Miki Kunitake of his own research group and with Jennifer Ng and Bruce Conklin of GICD on the embedded-nanowire project; their results are reported in the Journal of the American Chemical Society.

Stimulating cell identity

Differentiation is the process by which an embryonic stem cell acquires the unique morphological, genetic, and functional characteristics of a specific type of cell. While controlled by gene expressions, cell differentiation can also be influenced by signals from the surrounding environment, including electrical stimulation.

"Whether the signals are physical, chemical, or electrical, the overall effects of these stimuli will eventually control how a stem cell matures," says Yang. "By running an electrical current through a wired stem cell and varying the power through it, we may be able to direct how the cell differentiates."

The key to this possibility is being able to embed a living cell with an electrically conducting wire without otherwise impairing the cell's development. Previous attempts to physically puncture cells with nanowires or carbon nanotubes resulted in damage to the cell wall and often the death of the cell itself. Yang and his colleagues avoid this destruction by enabling the cells to gradually incorporate the nanowires by themselves, as they grow and develop.

The silicon nanowires were synthesized using a chemical vapor deposition technique developed earlier by Yang and his research group, in which nanosized gold particles serve as a catalyst to trigger the formation of millions of nanowires on the substrate. The precise size of the gold particles controls the diameter of the nanowires. When the silicon nanowires are exposed to air, a layer of silica (silicon dioxide) forms on their surface.

"Silica has a proven compatibility with the cell membrane and interior environment, which is one of the reasons we chose to work with silicon nanowires," says Yang. "Also, silicon is a conductor, which opens up the potential for introducing electrical stimulations into the cell."

In addition, silicon nanowires have a high aspect ratio — they can be a thousand times longer than they are thick — yet are rigid enough to be mechanically manipulated.


Science image

Left and center, two scanning electron microscope images of mouse embryonic stem cells growing on a silicon nanowire substrate. At right, a confocal microscope image shows the silicon nanowires as black dots inside the cells, which are glowing with green fluorescent protein.

Yang and his colleagues first tested the technique with embryonic stem cells from a mouse. Embryonic stem cells are notoriously sensitive to external stimulation, but when the test cells were grown in solution over the silicon nanowire array, they assimilated the nanowires and continued to thrive for more than a month.

The mouse embryonic stem cells used by Yang and his colleagues were on the cusp of differentiating into cardiac muscle cells. Because they had been engineered to express green fluorescent protein (GFP), a combination of confocal and scanning electron microscopy enabled the researchers to observe that each cell had indeed been embedded with several nanowires.

"Over time, as these cells proliferated, they began beating like a heart," says Yang.

A second round of tests involved human embryonic kidney cells. In these tests, each cell was embedded, on average, with two to three silicon nanowires. The nanowires measured between three and six microns in length, but three different diameters were tested, 30, 90 and 400 nanometers. (A micrometer is a millionth of a meter; a nanometer is a billionth of a meter.) Cells embedded with the 30- and 90-nanometer diameter wires — several orders of magnitude smaller than the cells — survived for up to a week, but those embedded with 400-nanometer wires died within a day.

"The longevity of these different cell types has not been systematically compared at this stage, but we can say that it is highly dependent on the diameter and density of the nanowires used in each set of experiments," says Yang. "Also, we need to do further research to understand the mechanism by which the silicon nanowires were taken up by the cells at the molecular level."



Science image Spacer image


Peidong Yang, a chemist who holds a joint appointment with Berkeley Lab and UC Berkeley, is one of the leading developers of nanosized wires and ribbons. In 2007 he won the Alan T. Waterman award in recognition of an outstanding young scientist who is revolutionizing research. (Photo Roy Kaltschmidt, Creative Services Office)


Yang and his colleagues also demonstrated the potential of their cell-wiring technique for delivering genes to specific regions of a cell's interior. They coated an array of silicon nanowires with plasmid DNA that codes for the green fluorescent protein. Then they incubated human embryonic kidney cells on top of the wires. One day later, some of the cells began expressing GFP, indicating a successful delivery and normal functioning of the GFP gene.

"We believe that the penetration of the nanowires into the cells promotes the retention of the cells on the substrate and therefore the gene delivery," says Yang. "As we perfect this technique, we should be able to pinpoint the delivery of genetic material within a spatial resolution of 50 nanometers, which is far more precise than any existing technique."

In addition to applications such as guiding stem cell differentiation and carrying out organelle-specific gene delivery, still down the road, Yang says the cell-wiring technique should quickly become a powerful research tool.

"Embedded silicon nanowires could be used as probes of individual cells, or for performing high-resolution, single-cell imaging, or high-resolution chemical and biological extractions," Yang says.

Additional information

  • "Interfacing silicon nanowires with mammalian cells," by Woong Kim, Jennifer K. Ng, Miki E. Kunitake, Bruce R. Conklin, and Peidong Yang, appears in the Journal of the American Chemical Society and is available online to subscribers.
  • More about Peidong Yang's research group
Source: Science@Berkeley Lab

Cranberries May Offer Natural Protection as Antibiotic Resistance Becomes a Major Public Health Concern

LAKEVILLE-MIDDLEBORO, Mass., Aug. 6 /PRNewswire/ -- Recent headlines suggesting consumers and doctors are doing everything they can to combat antibiotic resistance -- the immunity that bacteria develop to common prescriptions -- a natural alternative and household beverage just might be the ally they are looking for. Scientists have discovered that regular consumption of cranberry juice cocktail may offer protection against certain antibiotic resistant bacteria that cause urinary tract infections (UTIs). Maintaining a healthy urinary tract with cranberry juice cocktail may reduce the need for antibiotics by preventing the initial infection.

Research conducted jointly between Rutgers, The State University of New Jersey and the University of Michigan, suggests that regular consumption of cranberry juice cocktail could reduce the potential for development of UTIs, thus decreasing the need for antibiotics. In this study, scientists tested the effectiveness of cranberry juice cocktail in disabling a number of Escherichia coli (E. coli) bacteria, some of which are resistant to certain drugs.

E. coli bacteria are responsible for a host of health problems including urinary tract infections (UTIs) and have become increasingly resistant to certain drugs. Research shows that cranberries may provide an alternative to antibiotics especially in cases where E. coli bacteria have become resistant to treatment.

"With more and more awareness among health professionals and the public regarding antibiotic resistance, we are happy to report during our study when subjects consumed cranberry juice cocktail, their urine was capable of preventing antibiotic-resistant bacteria from adhering to cells from the urinary tract," said Amy B. Howell, Ph.D., research scientist at Rutgers, and lead investigator of the study.

Compounds in cranberries called proanthocyanidins (PACs) have been known to "disable" certain harmful bacteria in the body, helping to prevent infections. For example, in the case of urinary tract infections (UTIs), E. coli bacteria attach to bladder cells so that they can't multiply and cause an infection. According to a new study conducted by researchers from Worcester Polytechnic Institute, cranberry PACs disable E. coli bacteria and prevent the microorganisms from causing infection by changing the shape of the bacteria from rods to spheres, altering their cell membrane, and making it difficult for bacteria to make contact with cells, or from latching onto them should they get close enough. Other data has suggested that this "anti-adhesion" mechanism of action found in cranberry PACs may also help prevent certain bacteria from adhering to the stomach and the mouth, with implications for the prevention stomach ulcers and dental diseases.

Cranberry PACs anti-adhesion activity is primarily due to their unique A- type structure. While most other foods contain only the more-common B-type PACs, it is cranberry's A-type PACs that are responsible for this anti- adhesion mechanism of action. Since cranberry PACs also function as antioxidants, they provide a dual anti-adhesion and antioxidant health benefit. With more PACs and antioxidants per gram than most fruit, cranberries ward off certain bacteria and bolster the body's defenses against free radical damage that can contribute to many chronic diseases including heart disease.

While cranberry juice cocktail is one way, there are a variety of ways to get the cranberry's anti-adhesion benefits. One eight-ounce glass of cranberry juice cocktail contains just as many PACs as: 1/4 cup of fresh or frozen cranberries, 1/3 cup of sweetened dried cranberries, or 1/3 cup of cranberry sauce.

Ocean Spray is an agricultural cooperative owned by more than 650 cranberry growers in Massachusetts, Wisconsin, New Jersey, Oregon, Washington, British Columbia, and other parts of Canada as well as about 50 Florida grapefruit growers. Ocean Spray was formed 75 years ago by three cranberry growers from Massachusetts and New Jersey. Florida grapefruit growers joined the Cooperative in 1976. Ocean Spray is North America's leading producer of canned and bottled juices and juice drinks, and has been the best-selling brand name in the canned and bottled juice category since 1981. Ocean Spray posted fiscal 2006 sales of roughly $1.5 billion.

Source: Ocean Spray

Saturday, August 4, 2007

Toward An Alternative To Stem Cells For Treating Chronic Brain Diseases

Science Daily — With ethical issues concerning use of discarded embryos and technical problems hindering development of stem cell therapies, scientists in Korea are reporting the first successful use of a drug-like molecule to transform human muscle cells into nerve cells. This advance could lead to new treatments for stroke, Alzheimer's disease, Parkinson's disease and other neurological disorders.

Complete article can be found at Science Daily.

Scientists are developing a neural interface that can control the movement of individual fingers on a prosthetic hand.

By tapping directly into the brain's electrical signals, scientists at John's Hopkins University, in Baltimore, are on their way to developing a prosthetic hand more dexterous than ever before. They have demonstrated for the first time that neural activity recorded from a monkey's brain can control fingers on a robotic hand, making it play several notes on a piano.

Please visit MIT's Technology Review for the complete article.

Medtronic Receives FDA Approval To Market First Cervical Artificial Disc

WALTHAM, Mass., July 25 /PRNewswire/ -- Millennium Research Group (MRG) has conducted a detailed analysis of the US spinal implant market in its US Markets for Spinal Implants report. The analysis reveals that the cervical artificial disc market will reach a value of nearly $450 million in 2011. Medtronic Spinal and Biologic's Prestige Cervical Disc, which received approval from the FDA on July 16, is the first artificial disc for the neck. Other companies slated to release cervical artificial discs over the next several years include Synthes Spine, Stryker Spine, Globus Medical, SpinalMotion, Cervitech, DePuy Spine, LDR Spine, and Blackstone Medical.

Cervical artificial discs, such as Medtronic's Prestige, allow patients suffering from degenerative disc disease pain relief while maintaining mobility. Medtronic has agreed to run two different studies as part of the conditions of approval. One study is a 7-year process to evaluate effectiveness and long-term safety and the other is a 5-year enhanced surveillance study.

"Artificial discs were developed to treat chronic back pain while allowing for the preservation of physiological vertebral motion, proper intervertebral spacing, and stability," says Kevin Flewwelling, Senior Analyst at MRG. "In contrast to lumbar artificial discs, however, the cervical artificial disc market holds much more potential because surgeons are relatively more comfortable with the anterior cervical technique required for disc implantation."

The US Markets for Spinal Implants report is part of a global series that also includes Europe, Asia Pacific, and a number of emerging markets. Companies covered in this report series include Medtronic Spinal and Biologics, DePuy Spine, Synthes Spine, Stryker Spine, NuVasive, Abbott Spine, Blackstone Medical, Biomet Spine, Zimmer Spine, Kyphon, Solco Medical, Showa Medical, GS Medical Japan MDM, B.Braun/Aesculap, Scient'X, MBA Grupo and Wright Cremascoli. For ongoing quarterly tracking of market shares by brand, MRG offers its Marketrack service, which tracks the US Spinal Implant market and gathers quarterly data from 120 facilities performing spinal fusions. Besides market share, this service also provides brand level usage (units, average selling price, and revenue) and detailed procedure numbers by approach and instrumentation type.

About Millennium Research Group

Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResources.com), is the global authority on medical technology market intelligence and a leading provider of strategic information to the health care sector. Focused solely on the medical device, pharmaceutical, and biotechnology industries, the company provides its clients with the benefits of its specialized industry expertise through published reports and customized consulting services.

Source: Millennium Research Group

Saving Memories

Physicians can treat the symptoms of Alzheimer's disease and other neurodegenerative disorders, but there is no way to prevent or reverse the underlying degeneration and death of neurons that characterize these diseases. Now research by scientists at Harvard and MIT suggests a potential new therapeutic approach.

The complete article can be found at MIT's Technology Review

Nanogenerator Could Draw Energy from Human Blood

Scientists are working on a new type of nanogenerator that could draw the necessary energy from flowing blood in the human body, by using the beating heart and pulsating blood vessels. Once completed, this new cellular engine could find various applications, even beyond medicine.

For complete article please visit Softpedia